Evidence map›Paper›PMID 37228782›Full record

ArticleClinical, cosmetic and investigational dermatology2023

Efficacy of Oxybrasion and Cosmetic Acids on Selected Skin Parameters in the Treatment with Acne Vulgaris.

Karolina Chilicka, Monika Rusztowicz, Aleksandra M Rogowska, Renata Szyguła, Danuta Nowicka

Open access · goldAbstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Karolina ChilickaDepartment of Health Sciences, Institute of Health Sciences, University of Opole, Opole, Poland.
Monika RusztowiczDepartment of Health Sciences, Institute of Health Sciences, University of Opole, Opole, Poland.
Aleksandra M RogowskaDepartment of Social Sciences, Institute of Psychology, University of Opole, Opole, Poland.ORCID 0000-0002-4621-8916
Renata SzygułaDepartment of Health Sciences, Institute of Health Sciences, University of Opole, Opole, Poland.
Danuta NowickaDepartment of Dermatology, Venereology and Allergology, Wrocław Medical University, Wrocław, Poland.
University of Opole · PLWroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The present study aimed to evaluate the efficacy of an oxybrasion treatment applied alone and an oxybrasion treatment combined with cosmetic acids in improving acne-prone skin and selected skin parameters. Patients and Methods: A single-blind placebo study in a sample of 44 women diagnosed with acne vulgaris was conducted. Group A (n = 22) had a series of five oxybrasion treatments, while group B (n = 22) received a synergy of five oxybrasion treatments and a mixture of phytic, pyruvic, and lactic and lactic ferulic acids at 40% pH 1.4. Cosmetic treatments were performed every 14 days, and The Derma Unit SCC3 apparatus (Courage & Khazaka, Cologne, Germany) Sebumeter SM 815 and Corneometer CM825 and GAGS scale were used to check their effectiveness. Results: A Bonferroni post hoc test showed that group A and B did not differ from each other in acne severity before treatment ( Conclusion: Cosmetic treatments improved acne-prone skin and selected skin parameters. Better results were obtained by combining an oxybrasion treatment with cosmetic acids. Clinical Trial Approval: The clinical trial with ID ISRCTN 28257448 approved this study.

Indexed as

acne vulgariscorneometercosmetic acidsoxybrasionsebumeter

Identifiers

PMID37228782
PMCPMC10204714
OpenAlexW4377047210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.